The last two criteria look simple, but they have edge cases.
The event. "Had a reaction" or "had a problem" names no event: the report is not valid until the event is known. An outcome on its own ("was hospitalized", "died") with nothing about what happened is usually not valid either, and needs follow-up; but GVP VI says a sudden death would usually be handled as a suspected adverse reaction and the case submitted. If the reporter states that the drug did not cause the event, and the company agrees, there is no suspected reaction and the report is not a valid ICSR.
The product. A suspect product is the one the reporter suspects. A product the reporter thinks interacted with another is a suspect product too. When a literature article names only the active substance, the company presumes the product is its own unless it can tell from the country, the name, the form or other details that it is another company's, and says in the narrative that the brand was not identified.